WO1995000132A1 - Utilisation du modafinil pour le traitement des apnees du sommeil et troubles ventilatoires d'origine centrale - Google Patents
Utilisation du modafinil pour le traitement des apnees du sommeil et troubles ventilatoires d'origine centrale Download PDFInfo
- Publication number
- WO1995000132A1 WO1995000132A1 PCT/FR1994/000711 FR9400711W WO9500132A1 WO 1995000132 A1 WO1995000132 A1 WO 1995000132A1 FR 9400711 W FR9400711 W FR 9400711W WO 9500132 A1 WO9500132 A1 WO 9500132A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- modafinil
- treatment
- apneas
- sleep
- sec
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Definitions
- the present invention relates to a new use in therapy of modafinil.
- Modafinil or benzhydrylsulf inyl acetamide is a compound of formula:
- the present invention therefore relates to the use of modafinil for the manufacture of a medicament having a beneficial effect on the occurrence of apneas characterizing sleep apnea syndromes,
- the anti-apnea drug containing modafinil can be presented in particular in a form suitable for oral administration.
- the administered dose can be from 1 mg / kg to 100 mg / kg.
- apnea is defined as an interruption of the nasal-oral air flow exceeding a duration arbitrarily fixed at 10 seconds (Guilleminault C., Tilklan A., Dément WC.; Ann. Rev. Med., 1976, 27: 465-484).
- Three types of apnea are to be distinguished: apneas of central origin, apneas by obstruction of the respiratory tract, and so-called mixed apneas associating the two central and obstructive causes.
- Sleep apnea syndromes are conventionally defined by an apnea index greater than 5 apneas per hour of sleep. More recently, syndromes are defined by an apnea and hypopnea index greater than 10 events per hour of sleep.
- Oxyhemoglobin saturation was measured by transcutaneous oximetry measurement. Finally, the other gas parameters were measured using an automatic Corning gas analyzer. Clinical signs such as daytime sleepiness and quality of nighttime sleep were assessed using the clinical assessment scale and sleep diary completed by the patient and the clinical investigator. Modafinil was administered during the day, preferably in the morning and early afternoon. Unexpectedly, the results report an effect on the number of night apneas occurring during sleep and hypopnea. This number decreases significantly in 4 subjects out of 6 after 1 month of treatment, and in one subject out of 6 the apneas disappear completely from the records after treatment. The improvement in the number of apneas occurring during sleep seems to persist several days after the interruption of treatment. The doses of modafi ⁇ nil administered per day were 200 mg to 600 mg. As an example, the results obtained in a patient are presented in Table I comparing the results relating to apneas before and during treatment with modafinil.
- Modafinil treatment improved daytime sleepiness and improved nighttime sleep quality.
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Electrotherapy Devices (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Control Of Throttle Valves Provided In The Intake System Or In The Exhaust System (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU70760/94A AU684087B2 (en) | 1993-06-22 | 1994-06-14 | Use of modafinil for the treatment of sleep apnoea and ventilation problems of central origin |
AT94919708T ATE207351T1 (de) | 1993-06-22 | 1994-06-14 | Verwendung vonmodafinil zur behandlung von atemstillstand im schlaf und zentral erregten atembeschwerden |
US08/564,286 US5612379A (en) | 1993-06-22 | 1994-06-14 | Modafinil for the treatment of sleep apneas and ventilatory disorders of central origin |
JP50249895A JP3703831B2 (ja) | 1993-06-22 | 1994-06-14 | 中枢起原の睡眠無呼吸症及び呼吸疾患に対する効果を有する医薬の製造のためへのモダフィニルの使用 |
CA002165824A CA2165824C (fr) | 1993-06-22 | 1994-06-14 | Utilisation du modafinil pour la fabrication d'un medicament ayant un effet sur les apnees du sommeil et les troubles ventilatoires d'origine centrale |
DE69428791T DE69428791T2 (de) | 1993-06-22 | 1994-06-14 | Verwendung vonModafinil zur Behandlung von Atemstillstand im Schlaf und zentral erregten Atembeschwerden |
KR1019950705833A KR100315389B1 (ko) | 1993-06-22 | 1994-06-14 | 중추유래의수면성무호흡증및호흡곤란증에효과를갖는약제를제조하기위한모다피닐의사용 |
DK94919708T DK0705099T3 (da) | 1993-06-22 | 1994-06-14 | Anvendelse af modafinil til behandling af søvnapnø og åndedrætslidelser af central oprindelse |
EP94919708A EP0705099B1 (fr) | 1993-06-22 | 1994-06-14 | Utilisation du modafinil pour le traitement des apnees du sommeil et troubles ventilatoires d'origine centrale |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR93/07555 | 1993-06-22 | ||
FR9307555A FR2706767B1 (fr) | 1993-06-22 | 1993-06-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1995000132A1 true WO1995000132A1 (fr) | 1995-01-05 |
Family
ID=9448411
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR1994/000711 WO1995000132A1 (fr) | 1993-06-22 | 1994-06-14 | Utilisation du modafinil pour le traitement des apnees du sommeil et troubles ventilatoires d'origine centrale |
Country Status (14)
Country | Link |
---|---|
US (1) | US5612379A (fr) |
EP (1) | EP0705099B1 (fr) |
JP (1) | JP3703831B2 (fr) |
KR (1) | KR100315389B1 (fr) |
AT (1) | ATE207351T1 (fr) |
AU (1) | AU684087B2 (fr) |
CA (1) | CA2165824C (fr) |
DE (1) | DE69428791T2 (fr) |
DK (1) | DK0705099T3 (fr) |
ES (1) | ES2165878T3 (fr) |
FR (1) | FR2706767B1 (fr) |
HU (1) | HU216731B (fr) |
PT (1) | PT705099E (fr) |
WO (1) | WO1995000132A1 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5618845A (en) * | 1994-10-06 | 1997-04-08 | Cephalon, Inc. | Acetamide derivative having defined particle size |
US8580308B2 (en) | 2002-07-12 | 2013-11-12 | Cephalon, Inc. | Modafinil pharmaceutical compositions |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7160898B2 (en) * | 2001-12-14 | 2007-01-09 | Board Of Trustees Of The University Of Illinois | Pharmacological treatment for sleep apnea |
US20060241164A1 (en) * | 1998-02-27 | 2006-10-26 | The Board Of Trustees Of The University Of Illinoi | Pharmacological treatment for sleep apnea |
US6331536B1 (en) | 1998-02-27 | 2001-12-18 | The Board Of Trustees Of The University Of Illinois | Pharmacological treatment for sleep apnea |
US6492396B2 (en) | 2000-05-16 | 2002-12-10 | Cephalon, Inc. | Substituted thioacetamides |
ES2317943T3 (es) * | 2000-10-11 | 2009-05-01 | Cephalon, Inc. | Composiciones que comprenden compuestos de modafinilo. |
DE60219005T2 (de) * | 2001-05-25 | 2007-12-13 | Cephalon, Inc. | Modafinil umfassende feste pharmazeutische Formulierungen |
US20080058424A1 (en) * | 2002-05-23 | 2008-03-06 | Cephalon, Inc. | Novel pharmaceutical formulations of modafinil |
US7229644B2 (en) * | 2002-05-23 | 2007-06-12 | Cephalon, Inc. | Pharmaceutical formulations of modafinil |
US6992219B2 (en) * | 2002-08-09 | 2006-01-31 | Cephalon France | Modafinil polymorphic forms |
US20040116532A1 (en) | 2002-09-13 | 2004-06-17 | Craig Heacock | Pharmaceutical formulations of modafinil |
IL153098A0 (en) * | 2002-11-26 | 2003-06-24 | Chemagis Ltd | Pharmaceutical compositions containing modafinil |
US7528172B2 (en) * | 2003-01-21 | 2009-05-05 | The Cooper Health System, Inc. | Compositions and methods for improving recovery after general anesthesia |
CA2519117C (fr) * | 2003-03-17 | 2010-03-02 | Neurohealing Pharmaceuticals, Inc. | Traitement dopaminergique tres puissant de deficiences neurologiques associees a des lesions du cerveau |
US20040253308A1 (en) * | 2003-04-29 | 2004-12-16 | Barr Laboratories, Inc. | Surface-treated modafinil particles |
AR045423A1 (es) * | 2003-05-13 | 2005-10-26 | Cephalon Inc | Combinaciones de analiticos y antidepresivos |
US7368591B2 (en) | 2003-09-19 | 2008-05-06 | Cephalon France | Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation |
US7297817B2 (en) * | 2004-04-13 | 2007-11-20 | Cephalon France | Thio-substituted arylmethanesulfinyl derivatives |
US7119214B2 (en) * | 2004-04-13 | 2006-10-10 | Cephalon France | Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives |
EP1586560A1 (fr) * | 2004-04-13 | 2005-10-19 | Cephalon, Inc. | Dérivés arylméthanesulfinyles thio-substitués |
US7449481B2 (en) * | 2004-04-13 | 2008-11-11 | Cephalon, Inc. | Thio-substituted biaryl-methanesulfinyl derivatives |
US7314875B2 (en) * | 2004-04-13 | 2008-01-01 | Cephalon, Inc. | Tricyclic aromatic and bis-phenyl sulfinyl derivatives |
US7423176B2 (en) * | 2004-04-13 | 2008-09-09 | Cephalon, Inc. | Bicyclic aromatic sulfinyl derivatives |
AU2005319367B2 (en) * | 2004-12-20 | 2012-05-24 | Collegium Pharmaceutical, Inc. | Pharmaceutical compositions for sleep disorders |
AU2006272874B2 (en) * | 2005-07-21 | 2010-03-11 | Neurohealing Pharmaceuticals, Inc. | Rapid onset and short term modafinil compositions and methods of use thereof |
CA2657409A1 (fr) * | 2006-07-12 | 2008-01-17 | Elan Corporation, Plc | Formulations de nanoparticules de modafinil |
CA2660565C (fr) | 2006-08-14 | 2012-10-09 | Neurohealing Pharmaceuticals, Inc. | Traitement a base de modafinil contre l'ejaculation precoce |
US20080181966A1 (en) * | 2006-10-18 | 2008-07-31 | Cephalon, Inc. | Modafinil pharmaceutical compositions |
US20100010092A1 (en) * | 2006-12-19 | 2010-01-14 | Arless Ltd. | Use of modafinil to treat restless leg syndrome |
CA2786026A1 (fr) * | 2010-01-07 | 2011-07-14 | Vivus, Inc. | Traitement du syndrome d'apnees obstructives du sommeil avec une association d'un inhibiteur de l'anhydrase carbonique et d'un principe actif supplementaire |
EP3040078B1 (fr) | 2013-08-30 | 2021-02-24 | Green Cross Wellbeing Corporation | Composition destinée à prévenir et traiter la fatigue liée au cancer contenant de la poudre de ginseng traitée ou de l'extrait de ginseng traité comprenant un constituant de ginsénoside amélioré |
US9616068B2 (en) | 2014-10-27 | 2017-04-11 | Pohela LLC | Animal training using cognitive enhancement |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2385693A1 (fr) * | 1977-03-31 | 1978-10-27 | Lafon Labor | Derives d'acetamide utiles notamment en therapeutique |
EP0462004A2 (fr) * | 1990-06-14 | 1991-12-18 | Laboratoire L. Lafon | Nouvelle utilisation du modafinil |
FR2684875A1 (fr) * | 1991-12-13 | 1993-06-18 | Lafon Labor | Utilisation du modafinil pour la fabrication d'un medicament ayant un effet anti-ischemique. |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5281607B1 (en) * | 1992-10-08 | 1998-05-19 | Univ New York | Method of using alpha 2-antagonists for the treatment of neurodegenerative diseases |
-
1993
- 1993-06-22 FR FR9307555A patent/FR2706767B1/fr not_active Expired - Fee Related
-
1994
- 1994-06-14 EP EP94919708A patent/EP0705099B1/fr not_active Expired - Lifetime
- 1994-06-14 US US08/564,286 patent/US5612379A/en not_active Expired - Lifetime
- 1994-06-14 WO PCT/FR1994/000711 patent/WO1995000132A1/fr active IP Right Grant
- 1994-06-14 JP JP50249895A patent/JP3703831B2/ja not_active Expired - Lifetime
- 1994-06-14 DK DK94919708T patent/DK0705099T3/da active
- 1994-06-14 KR KR1019950705833A patent/KR100315389B1/ko not_active IP Right Cessation
- 1994-06-14 HU HU9503702A patent/HU216731B/hu unknown
- 1994-06-14 AU AU70760/94A patent/AU684087B2/en not_active Expired
- 1994-06-14 ES ES94919708T patent/ES2165878T3/es not_active Expired - Lifetime
- 1994-06-14 DE DE69428791T patent/DE69428791T2/de not_active Expired - Lifetime
- 1994-06-14 AT AT94919708T patent/ATE207351T1/de active
- 1994-06-14 PT PT94919708T patent/PT705099E/pt unknown
- 1994-06-14 CA CA002165824A patent/CA2165824C/fr not_active Expired - Lifetime
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2385693A1 (fr) * | 1977-03-31 | 1978-10-27 | Lafon Labor | Derives d'acetamide utiles notamment en therapeutique |
EP0462004A2 (fr) * | 1990-06-14 | 1991-12-18 | Laboratoire L. Lafon | Nouvelle utilisation du modafinil |
FR2684875A1 (fr) * | 1991-12-13 | 1993-06-18 | Lafon Labor | Utilisation du modafinil pour la fabrication d'un medicament ayant un effet anti-ischemique. |
Non-Patent Citations (1)
Title |
---|
C. GUILLEMINAULT ET AL.: "Daytime somnolescence: therapeutic approaches", NEUROPHYSIOL. CLIN., vol. 23, no. 1, 1993, pages 23 - 33 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5618845A (en) * | 1994-10-06 | 1997-04-08 | Cephalon, Inc. | Acetamide derivative having defined particle size |
USRE37516E1 (en) | 1994-10-06 | 2002-01-15 | Cephalon, Inc. | Acetamide derivative having defined particle size |
US8580308B2 (en) | 2002-07-12 | 2013-11-12 | Cephalon, Inc. | Modafinil pharmaceutical compositions |
Also Published As
Publication number | Publication date |
---|---|
FR2706767A1 (fr) | 1994-12-30 |
JPH09500374A (ja) | 1997-01-14 |
ES2165878T3 (es) | 2002-04-01 |
KR100315389B1 (ko) | 2002-02-19 |
CA2165824C (fr) | 2005-08-02 |
AU7076094A (en) | 1995-01-17 |
HUT74674A (en) | 1997-01-28 |
JP3703831B2 (ja) | 2005-10-05 |
AU684087B2 (en) | 1997-12-04 |
HU9503702D0 (en) | 1996-02-28 |
KR960703009A (ko) | 1996-06-19 |
US5612379A (en) | 1997-03-18 |
DE69428791T2 (de) | 2002-07-04 |
EP0705099B1 (fr) | 2001-10-24 |
EP0705099A1 (fr) | 1996-04-10 |
ATE207351T1 (de) | 2001-11-15 |
HU216731B (hu) | 1999-08-30 |
DK0705099T3 (da) | 2002-02-11 |
DE69428791D1 (de) | 2001-11-29 |
PT705099E (pt) | 2002-03-28 |
CA2165824A1 (fr) | 1995-01-05 |
FR2706767B1 (fr) | 1995-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2165824C (fr) | Utilisation du modafinil pour la fabrication d'un medicament ayant un effet sur les apnees du sommeil et les troubles ventilatoires d'origine centrale | |
Pekkarinen et al. | Sleep apnoea and daytime sleepiness in acromegaly: relationship to endocrinological factors | |
Whyte et al. | Role of protriptyline and acetazolamide in the sleep apnea/hypopnea syndrome | |
Schmidt et al. | Use of pramipexole in REM sleep behavior disorder: results from a case series | |
Clark et al. | Sleep apnea: treatment with protriptyline | |
Howard et al. | Encephalitis lethargica: a report of four recent cases | |
TWI335217B (en) | Pharmaceutical formulations of modafinil | |
SWANSON et al. | Myoclonus—a report of 67 cases and review of the literature | |
Erkinjuntti et al. | Sleep apnea in multiinfarct dementia and Alzheimer's disease | |
Stern et al. | Recent observations on the clinical pharmacology of (-) deprenyl | |
Rumbach et al. | Auditory event-related potentials in obstructive sleep apnea: effects of treatment with nasal continuous positive airway pressure | |
Parkes et al. | Levo (−) amphetamine and dextro (+) amphetamine in the treatment of narcolepsy | |
Sadasivam et al. | Anti-oxidant treatment in obstructive sleep apnoea syndrome | |
DE60111025T2 (de) | Verwendung von Topiramat zur Behandlung und Diagnostizierung von Atemstörungen während des Schlafens und Mittel zur Durchführung der Behandlung und Diagnose | |
JP2012197304A (ja) | ミオパシー関連性の覚醒障害を矯正することが意図される医薬品を製造するためのモダフィニルの使用 | |
JP2001509173A (ja) | 胃腸リパーゼ阻害剤の使用 | |
EP0563336A1 (fr) | Composition pharmaceutique contenant de l'acide gamma-hydroxybutyrique ou sa lactone et utilisee dans le traitement de la toxicomanie et des troubles nutritionnels | |
JP2501033B2 (ja) | D―フェンフルラミン含有うつ病用医薬組成物 | |
Guilleminault et al. | Periodic leg movement, sleep fragmentation and central sleep apnoea in two cases: reduction with Clonazepam | |
Fukuzako et al. | Postural myoclonus associated with long-term administration of neuroleptics in schizophrenic patients | |
Knezevic et al. | Neuroleptic malignant syndrome | |
Grøn | Bromocriptine versus placebo in levodopa treated patients with Parkinson's disease | |
Finch et al. | Relationship of fasting gastroduodenal motility to the sleep cycle | |
Guilleminault et al. | Periodic leg movement, L-dopa, 5-hydroxytryptophan, and L-tryptophan | |
Guilleminault et al. | Baclofen trial in six myotonic dystrophy patients |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA HU JP KR US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1994919708 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2165824 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1019950705833 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 1994919708 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 08564286 Country of ref document: US |
|
WWG | Wipo information: grant in national office |
Ref document number: 1994919708 Country of ref document: EP |